참고문헌
- Thompson MJ. Immunizations for international travel. Prim Care 2002;29:787-814. https://doi.org/10.1016/S0095-4543(02)00038-6
- Mutebi JP, Barrett AD. The epidemiology of yellow fever in Africa. Microbes Infect 2002;4:1459-68. https://doi.org/10.1016/S1286-4579(02)00028-X
- Monath TP, Cetron MS. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 2002; 34:1369-78. https://doi.org/10.1086/340104
- Martin M, Tsai TF, Cropp B, Chang GJ, Holmes DA, Tseng J, et al. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet 2001;358:98-104. https://doi.org/10.1016/S0140-6736(01)05327-2
- Post PR, de Carvalho R, da Silva Freire M, Galler R. The early use of yellow fever virus strain 17D for vaccine production in Brazil-a Review. Memorias Instituto Oswaldo Cruz 2001;96:849-57. https://doi.org/10.1590/S0074-02762001000600019
- Filippis AM, Nogueira RM, Jabor AV, Schatzmayr HG, Oliveira JC, Dinis SC, et al. Isolation and characterization of wild type yellow fever virus in cases temporally associated with 17DD vaccination during an outbreak of yellow fever in Brazil. Vaccine 2004;22:1073-8. https://doi.org/10.1016/j.vaccine.2003.11.002
- Monath TP. Yellow fever. In: Plotkin SA, Orenstein WA, Paul A, editors. Vaccines. 5th ed. Philadelphia: Elsevier, Inc, 2008:959-1055.
- Sood SK. Immunization for children traveling abroad. Pediatr Clin North Am 2000;47:435-48. https://doi.org/10.1016/S0031-3955(05)70216-9
- Monath TP. Yellow fever: an update. Lancet Infect Dis 2001;1:11-20. https://doi.org/10.1016/S1473-3099(01)00016-0
- Barnett ED. Yellow fever: epidemiology and prevention. Clin Infect Dis 2007;44:850-6. https://doi.org/10.1086/511869
- Barrett AD, Higgs S. Yellow fever: a disease that has yet to be conquered. Annu Rev Entomol 2007;52:209-29. https://doi.org/10.1146/annurev.ento.52.110405.091454
- Centron MS, Marfin AA, Julian KG, Gubler DJ, Sharp DJ, Barwick RS, et al. Yellow fever vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 2002;51: 1-11.
- Spira A. Yellow fever vaccine as a vehicle to better travel medicine. J Travel Med 2005;12:303-5. https://doi.org/10.2310/7060.2005.12601
- Fitzner J, Coulibaly D, Kouadio DE, Yavo JC, Loukou YG, Koudou PO, et al. Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast. Vaccine 2004;23:156-62. https://doi.org/10.1016/j.vaccine.2004.05.018
- Jong EC, Kaplan KM, Eves KA, Taddeo CA, Lakkis HD, Kuter BJ. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines. J Travel Med 2002;9:66-70. https://doi.org/10.2310/7060.2002.21955
- CDC. Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996-2001. MMWR Morb Mortal Wkly Rep 2001;50: 643-5.
- Pugachev KV, Guirakhoo F, Monath TP. New developments in flavivirus vaccines with special attention to yellow fever. Curr Opin Infect Dis 2005;18:387-94. https://doi.org/10.1097/01.qco.0000178823.28585.ad
- Lang J, Zuckerman J, Clarke P, Barrett P, Kirkpatrick C, Blondeau C. Comparison of the immunogenicity and safety of two 17D yellow fever vaccines. Am J Trop Med Hyg 1999;60:1045-50. https://doi.org/10.4269/ajtmh.1999.60.1045
- Collaborative Group for Studies with Yellow Fever Vaccine. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children : Implications for the Brazilian National Immunization Program. Vaccine 2007;25:3118-23. https://doi.org/10.1016/j.vaccine.2007.01.053
- Martins MA, Silva ML, Marciano AP, Peruhype- Magalhes V, Eloi-Santos SM, Ribeiro GL, et al. Activation/ modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse events following immunization? Clin Exp Immunol 2007;148:90-100. https://doi.org/10.1111/j.1365-2249.2006.03317.x
- Camacho LA, Freire Mda S, Leal Mda L, Aguiar SG, Nascimento JP, Iguchi T, et al. Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial. Rev Saude Publica 2004;38:671-8. https://doi.org/10.1590/S0034-89102004000500009
- Vasconcelos PF, Luna EJ, Galler R, Silva LJ, Coimbra TL, Barros VL, et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet 2001;358:91-7. https://doi.org/10.1016/S0140-6736(01)05326-0
- Chan RC, Penney DJ, Little D, Carter IW, Roberts JA, Rawlinson WD. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 2001;358:121-2. https://doi.org/10.1016/S0140-6736(01)05341-7
- Kitchener S. Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX. Vaccine 2004;22:2103-5. https://doi.org/10.1016/j.vaccine.2004.01.026
- Khromava AY, Eidex RB, Weld LH, Kohl KS, Bradshaw RD, Chen RT, et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 2005;23:3256-63. https://doi.org/10.1016/j.vaccine.2005.01.089
- CDC. Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002. MMWR Morb Mortal Wkly Rep 2002;51:989-93.
- Marfin AA, Eidex RS, Kozarsky PE, Cetron MS. Yellow fever and japanese encephalitis vaccines: indications and complications. Infect Dis Clin North Am 2005;19: 151-68. https://doi.org/10.1016/j.idc.2004.11.004
- Arya SC. Yellow fever vaccine safety: a reality or a myth? Vaccine 2002;20:3627-8. https://doi.org/10.1016/S0264-410X(02)00409-7
- Monath TP, Cetron MS, McCarthy K, Nichols R, Archambault WT, Weld L, et al. Yellow fever 17D vaccine safety and immunogenicity in the elderly. Hum Vaccin 2005;1:207-14.
- Engel AR, Vasconcelos PF, McArthur MA, Barrett AD. Charaterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine 2006;24:2803-9. https://doi.org/10.1016/j.vaccine.2006.01.009
- McGovern LM, Boyce TG, Fischer PR. Congenital infections associated with international travel during pregnancy. J Travel Med 2007;14:117-28. https://doi.org/10.1111/j.1708-8305.2006.00093.x
- Osei-Kwasi M, Dunyo SK, Koram KA, Afari EA, Odoom JK, Nkrumah FK. Antibody response to 17D yellow fever vaccine in Ghanaian infants. Bull World Health Organ 2001;79:1056-9.
- Rabello A, Orsini M, Disch J, Marcial T, Leal Md Mda L, Freire Md Mda S, et al. Low frequency of side effects following an incidental 25 times concentrated does of yellow fever vaccine. Rev Soc Bras Med Trop 2002; 35:177-80. https://doi.org/10.1590/S0037-86822002000200008
- Choudri Y, Walop W. Review of adverse events reported following use of fever vaccine-Canada, 1987-2000. Can Commun Dis Rep 2002;28:9-15.
- Robertson S. Yellow fever: the immunological basis for immunization. Document WHO/EPI/GEN/93. 181993.